Antibiotic loaded nanoparticles function through a mechanism known as targeted drug delivery. These nanoparticles can be functionalized with ligands or antibodies that bind specifically to receptors on cancer cells. Once bound, the nanoparticles are internalized by the cancer cells, releasing the antibiotic payload directly into the cell. This targeted approach ensures higher concentrations of the drug at the tumor site, enhancing its efficacy while reducing systemic toxicity.
